Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
pharmaceutical manufacturers in Europe:
sales of 43.55 billion Euros [US$49.31 billion]
of which 46%
of UNITED KINGDOM
(£33.75 billion [US$42.56 billion]
of which 52%
was Pharmaceuticals), and
based in SWITZERLAND
(48.29 billion Swiss Francs [US$51.48 billion]
of which 78%
was Innovative Medicines).
During the year ended December of 2019, sales at
Sanofi S.A. were 37.63 billion Euro (US$42.62 billion).
increase of 5.5%
versus 2018, when the company's sales were 35.68 billion Euro.
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
12.0% in 2019, from
5.12 billion Euro to 5.73 billion Euro.